Ethnobotanical Utilization of \u3cem\u3ePoecilineron pauciflorum\u3c/em\u3e Bedd. by the Kani Tribes of Agasthiamalai, Western Ghats, Tamil Nadu, India

This paper presents the Kani tribal uses of an endemic plant species, Poecilineuron pauciflorum Bedd. (Family Cluciaceae). The Kani tribals use it for the treatment of Mendel disorder and infectious diseases, and for exorcism activities. The information presented here was collected from the Kani community at Karaiyar, Kalakad Mundanthurai Tiger Reserve (KMTR) forest, South India, Tamil Nadu

How to Identify Rare and Endangered Ferns and Fern Allies

Identification of rare and endangered plant species is the first requirement for any conservation programme. The IUCN guideline is the only available method to identify the rare and endangered species and it requires vast data on the wild population of the target species. None of the biological characters, which are playing main role in the survival and distribution of several species, is used in IUCN guideline. In the meantime there are several difficulties in following IUCN guideline, particularly the non availability of complete field data. Moreover, the same guideline can not be used for all the groups of species in equal importance. The vascular cryptogams, pteridophytes, are also an important component of any mountainous flora and they have also to be conserved in nature. As they are the primitive vascular plants on the earth, they are getting depleted in the flora due to various reasons and it is the right time to identify the rare and endangered pteridophytes to conserve them. By considering various difficulties of IUCN method for the identification rare and endangered pteridophytes, a very simple method has been adopted by using just four criteria and this method can be applied to Pteridophytes from any region of the world

Ethnomedicinal Uses of Plants in the Plains Area of the Tirunelveli-District, Tamilnanu, India

India has a rich heritage of using medicinal plants for indigenous uses and practices. Some of the country\u27s best herbal medicines have also been introduced worldwide, and new applications have been found for them in different parts of the world. This new found fame , however, has proven to be troublesome for India in some instances. For example, the “turmeric case” highlights the problems faced by this country in preventing bio-piracy. Traditional systems of medicine such as Ayurveda, Sidda, Unani, and homeopathy make use of more than 2000 plant species. Local People, medicinal practitioners and tribal healers of this country where oral tradition is closely followed, have made some of our medicinal plants world famous as they find diverse applications across the world. Traditional systems of medicine make use of nearly 7000 plant species. Out of the 17,000 economic species of angiosperms known worldwide, about 5000 occur in India. Of these, 3000 are medicinal plants in which root drugs constitute the largest number of species (680) followed by drugs originating from fruits (450). Bearing the above facts in mind, an attempt has been made here to enumerate the medicinal plants available in the Tirunelveli plains, with help of local people and medicinal practitioners. Approximately three hundred fifteen plants were at one time medicinally used in the plains area of the Tirunelveli district, of which 95 have been treated in the following account

Glimpses of Tribal Botanical Knowledge of Tirunelveli Hills, Western Ghats, India

In the present paper, 46 plant species of angiosperms belonging to 19 genera of Euphorbiaceae that occur naturally in the Tirunelveli Hills of western Ghats, India, were chosen for study. It was found that the uses of Euphorbiaceous plants by the inhabitants of this region cover a number of broad categories including food, various kinds of poisons, medicines, sundry types of oils, waxes, rubbers, varnishes, compounds for paints and other industrial products

Quasi-one dimensional electrical conductivity and thermoelectric power studies on a discotic liquid crystal

We have studied the electrical conductivity of well aligned samples of hexahexylthiotriphenylene (HHTT) in the pure as well as doped states. The dopant used was a small concentration (0.62 mole %) of the electron acceptor trinitrofluorenone (TNF). In the columnar phases, doping causes the AC(1 kHz) conductivity along the columnar axis (σ ||) to increase by a factor of 107 or more relative to that in undoped samples; σ || attains a value of 10-2S/m, which was the maximum measurable limit of our experimental set up. On the other hand, in the isotropic phase doping makes hardly any difference to the conductivity. The frequency dependence of the conductivity has been investigated. The DC conductivity of doped samples exhibits an enormous anisotropy, σ ||/σ⊥ ≥ 1010, which is 7 orders higher than that reported for any liquid crystalline system, and, to our knowledge, the largest observed in an organic conductor. We also report the first thermoelectric power studies on these 'molecular wires'. The sign of the thermoelectric power is in conformity with the expected nature of the charge carriers, namely, holes

Radial nerve neurotmesis in closed humeral shaft fracture: unusual case

Radial nerve neurotmesis constitutes a major problem in the treatment of closed fractures of the mid-shaft of the humerus. A case of radial nerve neurotmesis associated with a closed fracture of mid-shaft of the humerus is reported. Radial nerve neurotmesis was found at the fractured site. Early exploration of the nerve and primary internal fixation of the fracture was done which gave a satisfactory result

Agile delivery of protein therapeutics to CNS

A variety of therapeutic proteins have shown potential to treat central nervous system (CNS) disorders. Challenge to deliver these protein molecules to the brain is well known. Proteins administered through parenteral routes are often excluded from the brain because of their poor bioavailability and the existence of the blood-brain barrier (BBB). Barriers also exist to proteins administered through non-parenteral routes that bypass the BBB. Several strategies have shown promise in delivering proteins to the brain. This review, first, describes the physiology and pathology of the BBB that underscore the rationale and needs of each strategy to be applied. Second, major classes of protein therapeutics along with some key factors that affect their delivery outcomes are presented. Third, different routes of protein administration (parenteral, central intracerebroventricular and intraparenchymal, intranasal and intrathecal) are discussed along with key barriers to CNS delivery associated with each route. Finally, current delivery strategies involving chemical modification of proteins and use of particle-based carriers are overviewed using examples from literature and our own work. Whereas most of these studies are in the early stage, some provide proof of mechanism of increased protein delivery to the brain in relevant models of CNS diseases, while in few cases proof of concept had been attained in clinical studies. This review will be useful to broad audience of students, academicians and industry professionals who consider critical issues of protein delivery to the brain and aim developing and studying effective brain delivery systems for protein therapeutics

SOD1 nanozyme salvages ischemic brain by locally protecting cerebral vasculature

Copper/zinc superoxide dismutase (CuZnSOD; SOD1) is widely considered as a potential therapeutic candidate for pathologies involving oxidative stress, but its application has been greatly hindered by delivery issues. In our previous study, nano-formulated SOD1 (cl-nanozyme) was shown to decrease infarct volume and improve sensorimotor functions after single intravenous (IV) injection in a rat middle cerebral artery occlusion (MCAO) model of ischemia/reperfusion (I/R) injury. However, it remained unclear how cl-nanozyme was able to deliver SOD1 to the brain and exert therapeutic efficacy. Present study aims to answer this question by exploring micro-distribution pattern of cl-nanozyme in the rat brain after stroke. Immunohistochemistry studies demonstrated cl-nanozyme co-localization with fibrin along damaged arteries and capillaries in the ischemic hemisphere. We further found that cl-nanozyme can be cross-linked into thrombi formed after I/R injury in the brain, and this effect is independent of animal species (rat/mouse) used for modeling I/R injury. This work is also the first report reinforcing therapeutic potential of cl-nanozyme in a well-characterized mouse MCAO model of I/R injury

Nano-particle delivery of brain derived neurotrophic factor after focal cerebral ischemia reduces tissue injury and enhances behavioral recovery

Low levels of brain-derived neurotrophic factor (BDNF) are linked to delayed neurological recovery, depression, and cognitive impairment following stroke. Supplementation with BDNF reverses these effects. Unfortunately, systemically administered BDNF in its native form has minimal therapeutic value due to its poor blood brain barrier permeability and short serum half-life. In this study, a novel nano-particle polyion complex formulation of BDNF (nano-BDNF) was administered to mice after experimental ischemic stroke